Ragia Georgia, Manolopoulos Vangelis G
Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100 Alexandroupolis, Greece.
DNALEX S.A., Leontaridou 2, Alexandroupolis, Greece.
Pharmacogenomics. 2018 Apr;19(6):513-516. doi: 10.2217/pgs-2018-0025. Epub 2018 Mar 27.
From the earliest times to the present, alcohol has evolved as part of life and culture. For most adults, moderate alcohol use is harmless, however, it lies at one end of a range that moves through alcohol abuse to alcohol addiction. Alcohol addiction is a serious and chronic psychiatric disorder that, on top of its heavy consequences on health, also brings significant social and economic losses to individuals and society at large. Pharmacotherapy of alcohol addiction exists, but its effectiveness varies significantly among individuals. Genomic and nongenomic factors are significant contributors to interindividual variation in the clinical presentation of alcohol problems and the response to a given treatment. In addition, emerging evidence suggests pharmacoepigenomics of alcohol addiction as a novel promising area for improvement of alcohol addiction management.
从远古时代至今,酒精已演变成生活和文化的一部分。对大多数成年人来说,适度饮酒无害,然而,它处于一个连续范围的一端,这个范围涵盖了从酒精滥用直至酒精成瘾。酒精成瘾是一种严重的慢性精神疾病,除了对健康造成严重后果外,还会给个人和整个社会带来重大的社会和经济损失。酒精成瘾的药物治疗是存在的,但其疗效在个体之间差异很大。基因组和非基因组因素是导致酒精问题临床表现及对特定治疗反应个体差异的重要因素。此外,新出现的证据表明,酒精成瘾的药物表观基因组学是改善酒精成瘾管理的一个充满希望的新领域。